{"timestamp": 1771604715.5433333, "value": {"ticker": "RLMD", "company_name": "Relmada Therapeutics, Inc.", "short_name": "Relmada Therapeutics, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 312203232, "float_shares": 57053558, "shares_outstanding": 73333622, "short_ratio": 2.29, "short_percent_of_float": 0.0173, "shares_short": 1256360, "shares_short_prior": 1388226, "insider_percent_held": 0.10751, "institution_percent_held": 0.68292, "total_cash": 13886524, "total_debt": 0, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 0, "current_ratio": 2.862, "book_value": 0.285, "price_to_book": 14.937895, "operating_cashflow": -39990400, "free_cashflow": -20166900, "price": 4.2573, "52w_high": 5.12, "52w_low": 0.24, "avg_volume": 777415, "avg_volume_10d": 574030, "full_time_employees": 17, "audit_risk": 8, "overall_risk": 8}}